BlackRock Fund Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $180M | Buy |
2,841,646
+301,221
| +12% | +$19.1M | 0.03% | 741 |
|
|
2016
Q3 | $162M | Buy |
2,540,425
+189,678
| +8% | +$12.1M | 0.03% | 675 |
|
|
2016
Q2 | $175M | Buy |
2,350,747
+143,410
| +6% | +$10.7M | 0.04% | 571 |
|
|
2016
Q1 | $147M | Buy |
2,207,337
+38,422
| +2% | +$2.57M | 0.03% | 655 |
|
|
2015
Q4 | $147M | Buy |
2,168,915
+813
| +0% | +$55K | 0.03% | 674 |
|
|
2015
Q3 | $116M | Buy |
2,168,102
+119,664
| +6% | +$6.39M | 0.03% | 790 |
|
|
2015
Q2 | $129M | Sell |
2,048,438
-88,374
| -4% | -$5.56M | 0.03% | 790 |
|
|
2015
Q1 | $103M | Buy |
2,136,812
+89,715
| +4% | +$4.32M | 0.02% | 980 |
|
|
2014
Q4 | $68M | Buy |
2,047,097
+58,338
| +3% | +$1.94M | 0.02% | 1245 |
|
|
2014
Q3 | $58.3M | Sell |
1,988,759
-93,379
| -4% | -$2.74M | 0.02% | 1259 |
|
|
2014
Q2 | $80.9M | Sell |
2,082,138
-89,927
| -4% | -$3.49M | 0.02% | 1059 |
|
|
2014
Q1 | $91.2M | Buy |
2,172,065
+59,024
| +3% | +$2.48M | 0.03% | 926 |
|
|
2013
Q4 | $69.3M | Buy |
2,113,041
+950,194
| +82% | +$31.2M | 0.02% | 1150 |
|
|
2013
Q3 | $31.4M | Buy |
1,162,847
+149,783
| +15% | +$4.04M | 0.01% | 1662 |
|
|
2013
Q2 | $23.6M | Buy |
+1,013,064
| New | +$23.6M | 0.01% | 1734 |
|